**Author Information** An event is serious (based on the ICH definition) when the patient outcome is:\* death\* life-threatening\* hospitalisation\* disability\* congenital anomaly\* other medically important event

In a case series, an 82-year-old woman and a 69-year-old man developed hypothermia, bradycardia and cardiac arrest following treatment with risperidone \[*routes, dosages and durations of treatments to reactions onsets not stated*\].

Case 1: The 82-year-old woman, who had dementia, schizophrenia and atrial fibrillation, presented for worsening confusion. Her family reported involuntary spasmodic movements of the upper and lower extremities. She had been receiving treatment with metoprolol, warfarin and risperidone for over 4 years. Physical examinations showed hypotension, bradycardia, hypothermia and impaired mentation with Glasgow Coma Score (GCS) of 10. Blood workup, urinalysis and urine toxicology was found to be unremarkable. ECG showed sinus bradycardia and J waves. She received IV crystalloid resuscitation and, unspecified broad-spectrum antibiotics and steroids. She was admitted to the intensive care unit (ICU). She was given vasopressor support. Following 12 hours of the presentation, she developed cardiac arrest with pulseless electrical activity. Her body temperature prior to cardiac arrest was 35.5 °C. She was initiated on Advanced Cardiac Life Support protocol followed by intubation and mechanical ventilation. Laboratory investigations were unremarkable. Based on the laboratory investigations, risperidone was considered as the cause of her hypothermia, bradycardia and cardiac arrest. Naranjo probability scale of adverse drug reactions between risperidone and hypothermia, bradycardia and cardiac arrest was considered as probable. Therefore, risperidone was discontinued. She was weaned off of the ventilator and vasopressor support. Eventually, she regained her baseline status. She was discharged.

Case 2: The 69-year-old man, who had diabetes mellitus, hypertension, chronic obstructive pulmonary disease, schizophrenia and peripheral vascular disease, presented to emergency department for worsening confusion and weakness. He had been receiving risperidone, lisinopril, terazosin, finasteride, insulin and metformin. At presentation, he had bradycardia and hypothermia. He was drowsy and lethargic with a GCS of 13. Laboratory investigations were unremarkable except thrombocytopenia. Active external rewarming was promptly initiated. He was admitted to the ICU. He was started on IV hydration and unspecified broad-spectrum antibiotic. Subsequently, he developed hypotension, cardiac arrest with pulseless electrical activity. His body temperature prior to cardiac arrest was 33 °C. He was resuscitated. However, he developed ventricular fibrillation. He was defibrillated twice. After 9 minutes, he regained systemic circulation. He was started on amiodarone. He was intubated and mechanical ventilation was started. Follow-up ECG showed no ST elevation. ECG was consistent with normal ejection fraction and no overt abnormalities. With supportive measures and cessation of antipsychotics, he was stabilised, and was liberated from the ventilator. Further, cardiac catheterisation revealed non-obstructive multi-vessel coronary artery disease. Risperidone was considered as the cause of his hypothermia, bradycardia and cardiac arrest. Therefore, risperidone was discontinued.
